N. Oswald et H. Bateman, Applying research evidence to individuals in primary care: a study using non-rheumatic atrial fibrillation, FAM PRACT, 16(4), 1999, pp. 414-419
Background. There is strong research evidence that anticoagulation of patie
nts with nonrheumatic atrial fibrillation reduces the morbidity and mortali
ty of stroke. This evidence is incompletely applied.
Objectives. We aimed to report consequences associated with the intention t
o apply evidence about anticoagulation for non-rheumatic atrial fibrillatio
n (NRAF), to individuals in general medical practice.
Methods. The study involved prospective structured reporting of the process
es of applying evidence about NRAF to individual patients in six general pr
actices in Cambridge. The subjects were patients identified to have NRAF in
these practices. The intervention consisted of a practice-based review of
evidence and the construction of a practice-owned protocol. This was follow
ed by a review of individual patients' records according to protocol criter
ia. The main outcomes were indentification of the characteristics of the pa
tients, quantitation of GPs' intention to change treatment, explicit report
ing of the reasons for not anticoagulating individuals and time to achieve
the practice protocol.
Results. The data collected confirmed that patients excluded from the autho
ritative randomized controlled trials predominate among patients cared for
in general medical practice. Practitioners overestimated the prevalence of
NRAF in their patients and underestimated the extent to which their current
practice offered intervention. Practitioners initially overestimated the a
mount of change required in patient management. In reviewing their patients
' records with the intention of following evidence-based practice, practiti
oners explicitly described and regarded as appropriate their reasons for no
t prescribing anticoagulation to certain individuals. The review process wa
s time-consuming and will need to be repeated as further evidence emerges.
Conclusion. Evidence of the complexity of applying trial results to general
practice patients with NRAF is confirmed and extended.